DataZymes Strategy and Insights for increased efficiency, profitability, and durability
At DataZymes, our focus is to identify and leverage the best approaches and
tools to extract insights in an ever-changing disease landscape. We translate
the findings into strategic recommendations to support your organization’s
tactical and strategic decision-making.
Therapeutic and Portfolio Strategy
DataZymes offers portfolio and brand planning support to global Pharma companies. Our outputs typically cover the following areas: therapy area/disease area profiling, developing situational analysis, scenario planning, and Business Development & Licensing Support.
Epidemiology, market segmentation, and clinical landscape assessment assimilated to ‘White Space Mapping’ around the current and future evolution of disease/therapeutic areas.
For competitor positioning at each stage. Empowering the key drivers for continuous and stable growth of a product through a new market segment or LCM strategies during pre-launch and launch.
Identifying opportunities through multiple filters and subsequently screening the opportunities on “clinical and commercial attractiveness”
DataZymes’ scientific competitive intelligence services offer continuous support to brand and marketing teams, by collating large data sets and secondary reports supplemented with focused primary research. Our outputs typically include the following areas: clinical trial landscape analysis, pipeline and endpoints analysis, competitor deep dives, product-level analysis, and other kinds of ad hoc CI analysis as needed.
For in-depth analysis of competitor pipeline by Phase, MoA, Sponsors, and Patient segment; Endpoint can be mentioned in the 'Clinical trial intelligence'
For comparison of likely marketing claims and target product profiles through a dynamic and robust benchmarking of clinical trial design.
For collecting information based on KITs/KIQs around competitor products and analyzing the clinical data presented, putting the primary and secondary research together.
For catering the client needs through customized profiles focused on clinical, regulatory, and commercial sectors of competitors.
“Continuous monitoring” of events with impactful takeaways that helps client to stay as a front runner and ahead of the competition
DataZymes specializes in developing patient-based and prescription-based sales forecasting for clients in the pharmaceutical and biotechnology domains. We use a patient-based model to develop a forecast for products. We deploy robust forecast methodologies and a user-friendly interface to estimate market size, patient shares, and market shares.
For strategic financial planning our epidemiology-based forecast models are logically laid out to accurately capture the calculation steps for the forecast. We use bottom-up patient flow approaches to estimate Market Size, Patient Shares, and market shares for products.
For continuous forecasting support on marketed brands we use historical data and apply multiple statistical techniques for maintaining and updating monthly demand forecasts.
For rapid deployment our Data modelers can build template-driven sophisticated but simple and easy to use forecast models
Deep Experience Across Key Therapeutic Areas
DataZymes has experience in providing consulting services across a range of therapeutic areas.